Zhang Lei, Zhu Wei
Kunshan Hospital of Traditional Chinese Medicine, Kunshan, China.
J Anal Methods Chem. 2024 Oct 16;2024:5514265. doi: 10.1155/2024/5514265. eCollection 2024.
Yiwei decoction (YWD) is a classic prescription with the function of nourishing stomach yin. In this study, the effective components of antioxidant activity of YWD and its possible mechanism were discussed from the point of view of spectral effect relationship and network pharmacology. Firstly, the fingerprints of 10 batches of YWD were established by UPLC-PDA technique, and the 1,1-diphenyl-2-picryl-hydrazyl radical (DPPH) scavenging rate and total antioxidant capacity (T-AOC) were used as the indicators for antioxidant activity in vitro. Then, the spectral effect relationship between the fingerprint profiles and antioxidant capacity was analyzed through grey relational analysis (GRA) and orthogonal projections to latent structures (OPLS). In addition, network pharmacology was employed to predict the potential mechanisms of YWD in the treatment of antioxidant-related diseases. The spectrum-effect relationship indicated that three common peaks were likely to be the most decisive active components, identified as verbascoside, psoralen, and vitexin, respectively. Based on network pharmacology analysis, a total of 83 target genes shared by the active components and antioxidant-related diseases were collected. AKT1, HSP90AA1, SRC, CASP3, and MTOR were closely related to antioxidant therapy and considered as core therapeutic targets. The potential mechanisms of YWD were obtained through gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Finally, molecular docking simulations were conducted to evaluate the binding activities between the core therapeutic targets and corresponding compounds. The excellent core protein-compound complexes obtained by molecular docking were simulated by molecular dynamics simulation. The results showed that the active compounds had good binding ability with the selected targets. This study successfully identified the effective components of YWD and predicted the potential targets and pathways, which provided a new idea for the application of YWD in the treatment of antioxidant stress in the future. In addition, the potential active components provide valuable implications for drug screening of related diseases.
益胃汤是一种具有滋养胃阴功能的经典方剂。本研究从谱效关系和网络药理学角度探讨了益胃汤抗氧化活性的有效成分及其可能机制。首先,采用超高效液相色谱-光电二极管阵列检测技术(UPLC-PDA)建立了10批次益胃汤的指纹图谱,并以1,1-二苯基-2-苦基肼自由基(DPPH)清除率和总抗氧化能力(T-AOC)作为体外抗氧化活性指标。然后,通过灰色关联分析(GRA)和正交投影到潜在结构(OPLS)分析指纹图谱与抗氧化能力之间的谱效关系。此外,运用网络药理学预测益胃汤治疗抗氧化相关疾病的潜在机制。谱效关系表明,3个共有峰可能是最具决定性的活性成分,分别鉴定为毛蕊花糖苷、补骨脂素和牡荆素。基于网络药理学分析,共收集到活性成分与抗氧化相关疾病共有的83个靶基因。蛋白激酶B1(AKT1)、热休克蛋白90α家族成员1(HSP90AA1)、肉瘤病毒癌基因(SRC)、半胱天冬酶3(CASP3)和哺乳动物雷帕霉素靶蛋白(MTOR)与抗氧化治疗密切相关,被视为核心治疗靶点。通过基因本体论(GO)和京都基因与基因组百科全书(KEGG)获得了益胃汤的潜在作用机制。最后,进行分子对接模拟以评估核心治疗靶点与相应化合物之间的结合活性。通过分子动力学模拟对分子对接得到的优良核心蛋白-化合物复合物进行模拟。结果表明,活性化合物与所选靶点具有良好的结合能力。本研究成功鉴定了益胃汤的有效成分,预测了潜在靶点和通路,为益胃汤未来在抗氧化应激治疗中的应用提供了新思路。此外,潜在活性成分对相关疾病的药物筛选具有重要意义。